Artiva Biotherapeutics (ARTV) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $3.5 million.
- Artiva Biotherapeutics' Other Gross PP&E Adjustments rose 26075.66% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 26075.66%. This contributed to the annual value of -$1.5 million for FY2024, which is 6948.57% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Other Gross PP&E Adjustments stood at $3.5 million for Q3 2025, which was up 26075.66% from $1.3 million recorded in Q2 2025.
- Over the past 5 years, Artiva Biotherapeutics' Other Gross PP&E Adjustments peaked at $3.5 million during Q3 2025, and registered a low of -$4.9 million during Q4 2023.
- Over the past 3 years, Artiva Biotherapeutics' median Other Gross PP&E Adjustments value was -$1.5 million (recorded in 2024), while the average stood at -$963000.0.
- In the last 5 years, Artiva Biotherapeutics' Other Gross PP&E Adjustments surged by 6948.57% in 2024 and then skyrocketed by 26075.66% in 2025.
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Other Gross PP&E Adjustments stood at -$4.9 million in 2023, then surged by 69.49% to -$1.5 million in 2024, then surged by 334.98% to $3.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at $3.5 million for Q3 2025, versus $1.3 million for Q2 2025 and $109000.0 for Q1 2025.